Breadcrumb AMCP.org Policy & Advocacy Letters, Statements & Analysis AMCP Submits Comments to the Ohio Senate Health and Human Services Committee, Opposing Sub. HB No. 505, a Bill Concerning Biosimilars AMCP Submits Comments to the Ohio Senate Health and Human Services Committee, Opposing Sub. HB No. 505, a Bill Concerning Biosimilars 5/27/16 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page MA Sub. H.B. No. 505.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page